Assessing additional benefit in noninferiority trials

DOI10.1002/BIMJ.201300227zbMath1403.62202OpenAlexW1958749714WikidataQ48263630 ScholiaQ48263630MaRDI QIDQ2792768

Kathrin Stucke, Meinhard Kieser

Publication date: 14 March 2016

Published in: Biometrical Journal (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1002/bimj.201300227

zbMATH Keywords

multiplicityadditional benefitaverage type I error ratecoprimary endpointsnoninferiority trials

Mathematics Subject Classification ID

Estimation in multivariate analysis (62H12) Time series, auto-correlation, regression, etc. in statistics (GARCH) (62M10) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (1)

Non-inferiority testing for risk ratio, odds ratio and number needed to treat in three-arm trial

Cites Work

• Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables
• Challenges to multiple testing in clinical trials
• Comparison of treatments in a combination therapy trial

This page was built for publication: Assessing additional benefit in noninferiority trials